Corporate Headquarters

 

Injectsense, Inc.
2000 Powell St

Suite 1425 
Emeryville, CA 94608

 

(510) 292-4120
 

 

 

Twin Cities

 

Injectsense, Inc.

7825 Washington Ave. South

Suite 650

Minneapolis, MN 55439

 

 

 

 

  • LinkedIn Social Icon
  • Twitter Social Icon
  • Google+ Social Icon
  • YouTube Social  Icon
  • Facebook Social Icon

TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

INVESTORS

INVESTORS

TECHNOLOGY

RESOURCES

RESOURCES

RESOURCES

TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

TECHNOLOGY

RESOURCES

1/4

Measuring Therapy Effectiveness Through Sensing and Data Control  

 

Find out how we are transforming the medical industry through continuous sensing, computing and transmission to provide the configurable data that physicians need.

 

We've started with intraocular pressure (IOP) sensing to help assess glaucoma therapy effectiveness.

 

 

Careers

Emeryville  |  Twin Cities

Events

JP Morgan Healthcare

January 13-16

San Francisco, CA

Glaucoma 360 New Horizons Forum

February 7

San Francisco, Ca

ARVO 2020

May 3-7

Baltimore, MD

ASCRS-ASOA

May 15-19

Boston, MA 

 

 

Investors

Injectsense received Series B funding in April of 2019, and is currently engaged in fundraising for Series C. 

Technology

 

Our smart sensor is a self-anchoring platform that interfaces well with media (blood, tissue, other fluids) without interfering with the electronics that support the sensing, computing and transmission of data.

The Injectsense Difference

 

Take a look at how the company's Silicon Valley and Twin Cities product teams combine cutting-edge advances in microelectronics with best-in-class medical device development and expertise. 

CAUTION - Investigational Device. Limited by Federal law to investigational use.

.